ADOLORE BIOTHERAPEUTICS

Startup

ADOLORE BIOTHERAPEUTICS

Description

Adolore Biotherapeutics develops non-opioid analgesic gene therapy designed for treating pain for what it is: a DISEASE

ADOLORE BIOTHERAPEUTICS

Address

Contact

mlevitt@adolore.com

Description

Adolore Biotherapeutics develops non-opioid analgesic gene therapy designed for treating pain for what it is: a DISEASE

Matchmaking

Connect with ADOLORE BIOTHERAPEUTICS

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL